Navigation Links
Healthy Hands Week: June 8-12, 2009
Date:4/28/2009

ialized care provided by this outstanding group of professionals and the importance of maximizing hand function to keep people healthy."

Hand therapists enhance the lives of patients by restoring functional activity through specialized skills in assessment and treatment. They also specialize in prevention of hand injuries, by providing guidelines and exercises suitable for use with everyday activities such as gardening, cooking and use of portable electronics. Visit www.asht.org for additional information.

For more information about Healthy Hands Week or to find a professional hand therapist in your area, visit www.asht.org.

The American Society of Hand Therapists is a not-for-profit organization seeking to advance the specialty of hand therapy through communication, education, research and the establishment of clinical standards. ASHT's 3,300 members in the United States, Canada and around the world strive to be recognized leaders in the hand therapy profession.


'/>"/>
SOURCE The American Society of Hand Therapists
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. UCLA researchers identify markers that may predict diabetes in still-healthy people
3. Air pollution linked to cardiovascular risk indices in healthy young adults
4. Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe)
5. Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees
6. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
7. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
8. On September 7th Local Organizations Partner to Celebrate Healthy Steps
9. September is Healthy Aging Month
10. Children who learn heart healthy eating habits lower heart disease risk
11. FDA: Use the Nutrition Facts Label to Make Healthy Food Choices

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...DanielTouizer,CEOof Ci n e r gyHealth ,anati...fitprograms,isconcernedthatthelabordepartment,srec...sarewithoutafull-timejobandunlikelytohavehealthins...ytheU-6number,whichhasspikedto17.5%,thehighestrate...estatisticsarealarmingasitmeansthatmanyAmericansdo...
(Date:11/25/2009)...tial to normal human development - the Wnt/Wingles...) pathways - interact in ways that can promote tum...The University of Texas M. D. Anderson Cancer Cent.... , This newly characterized interaction involve...th invasive cancer - activation of EGFR, elevated ...
(Date:11/25/2009)...Hematology (ASH) is pleased to recognize the follo... abstracts in the categories of undergraduate stud...physician, and post-doctoral,fellow. Merit Award ...ing,travel reimbursement. , The 2009 Merit Awar... Kimberly Fan , Donor Dendritic Cells Home to Lym...
(Date:11/25/2009)...nch . , , Montreal, November 25, 2009 Cuttin...lace, thanks to a new partnership between Gestion ...tive Sensing Inc. (CSI), a privately owned technol... commercializes discoveries from the Universit de ...ave announced the signature of a license agreement...
(Date:11/25/2009)...Southwestern Medical Center soon will begin implan... patients with upper spinal-cord injuries or other...tly. , UT Southwestern University Hospital St....ne of 25 in the country currently equipped to impl...System. , The device is designed to give patient...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:ASH announces 2009 Merit Award winners 2Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2Health News:New device implanted by surgeons help paralyzed patients breathe easier 2
... Unveiled at POH Riley Foundation,s Nov. 17...rysler Jeep Superstores Will Help Foundation Break...is Year,s Gala, BIRMINGHAM, Mich., Nov. 13 Needy...atrician check-ups,with the generous donation of a...
...k for obesity often focus on improving eating habi...ty. While this is one way to address the issue, an...could simply come down to positive parenting, acco... neglect in childhood and childhood obesity. Previ...
...nucleotides encoding some of the bodies, 20 amino ...normal expansion of trinucleotide repeats is the k... disorders, including Huntington disease. , Scien...of a normal repeated DNA sequence alters gene expr...
...r pancreatic surgery, most notably bleeding, infec...n can also be seen due to internal hernias or anas...wel obstruction in this setting is intussusception...ed by Dr. Luis Leons group on the November 28 issu...
...ns to deliver a comprehensive drug ...ISCO, Nov. 13 ORACLE OPENWORLD 2007 -- Tata,Consu... a leading global IT,services, business solutions ... integrated & comprehensive Drug Safety,and Pharma...
...., Nov. 13 ,PDX- NHIN and Health Market Science of...entered into an agreement to jointly market to PDX...ile(TM), a database which currently,contains over ...0071026/NEF019LOGO ) Jeff Farris, PDX-NHIN-Rx.co...
Other Medicine News:Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 2Health News:Needy Women and Children in Oakland County Get Big Boost for Free Health Care With Donation of Two-Year Lease for Chrysler 300C 3Health News:A higher risk of obesity for children neglected by parents 2Health News:Antegrade bowel intussusception can cause recurrent, chronic postoperative intestinal obstruction 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 2Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 3Health News:TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM) 4Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 2Health News:PDX-NHIN and Health Market Science to Jointly Market Standardized Prescriber File 3
(Date:11/25/2009)....25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABA...arebloodanalysissystems,announcedtodaythatClintSev...atthe21stAnnualPiperJaffrayHealthCareConferenceonW...illbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...andmarketsportablebloodanalysissystemsforuseinanyv...
(Date:11/25/2009)...wswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),am...inimallydisruptivesurgicaltreatmentsforthespine,an...November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfere...mentfortheCompany,sproductsandwillincludecommentsf...ion.Thedial-innumbersare1-877-407-4018fordomesticc...
(Date:11/25/2009)...swire/--Reportlinker.comannouncesthatanewmarketres...nasalDrugDelivery-USMarketTrends&Analysis htt...Delivery---US-Market-Trends--Analysis.html ,, ...ansionoftherapeuticapplicationsfromthedeliveryofco...emictherapeuticdrugs.Thefutureofthetechnologyhinge...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Sentry Data Systems Announces Claims Guardian 28TM 29 50150 1Sentry Data Systems Announces Claims Guardian 28TM 29 50150 2Sentry Data Systems Announces Claims Guardian 28TM 29 50150 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 1Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 2Brown Takes Over Reins as Chair of AOSSM Medical Publishing Board of Trustees 50148 3
...dy Comparing Leading Hepatitis C Therapies Provide...cal Practice, MILAN, Italy, April 26 Final resul..., clinical study comparing the,leading therapies f...e 43rd,Annual Meeting of the European Association ...tant insights that may help guide clinical practic...
...ts achieve undetectable HCV RNA levels following 4...egasys(R) plus Copegus(R) -, - Safety and tolerabi...ys plus Copegus - ...bsite -, - Conference call scheduled for Friday, A... and 7:00 PM CEST (Milan) -, PRINCETON, N.J. ...
Other Medicine Technology:Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 2Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 3Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 4Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 5Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 6Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 7Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 8Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 9Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL) 10Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 2Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 3Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 4Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 5Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C 6
Ultra-Sensitive Testosterone EIA
...kes it possible to determine the,vitamin levels in...es all reagents in,ready to use form for preparati... the columns. ,The advantage of HPLC analytics is ...ngle test. The HPLC complete,system enables even l...
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...st kit is intended for the quantitative determinat...eptionally sensitive ELISA procedure offers sensit...iding for accurate establishment of post-ablation ...l methods. Furthermore, with the ability to accura...
Medicine Products: